Rosenblatt Initiates Coverage On Quantinuum with Buy Rating, Announces Price Target of $155

Benzinga Newsdesk www.benzinga.com Neutral 51.9%

Neg 0% Neu 51.9% Pos 0%

Rosenblatt analyst John McPeake initiates coverage on Quantinuum (NASDAQ:QNT) with a Buy rating and announces Price Target of $155.